blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1426440

EP1426440 - NOVEL RFRP-3 AND DNA THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.04.2011
Database last updated on 21.08.2024
Most recent event   Tooltip11.10.2013Lapse of the patent in a contracting state
New state(s): ES
published on 13.11.2013  [2013/46]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome, Chuo-ku
Osaka / JP
[2010/24]
Former [2005/01]For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka / JP
Former [2004/24]For all designated states
Takeda Chemical Industries, Ltd.
1-1 Doshomachi 4-chome, Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
Inventor(s)01 / HINUMA, Shuji
7-9-1402, Kasuga 1-chome
Tsukuba-shi, Ibaraki 305-0821 / JP
02 / YOSHIDA, Hiromi
1444-23, Oaza Kossho
Ishige-machi, Yuki-gun, Ibaraki 300-2741 / JP
03 / HABATA, Yugo
17-1-606, Namiki 3-chome
Tsukuba-shi, Ibaraki 305-0044 / JP
04 / HOSOYA, Masaki
711-83, Itaya 1-chome
Tsuchiura-shi, Ibaraki 300-0007 / JP
05 / KITADA, Chieko
2-8, Minamikoyocho 1-cho
Sakai-shi, Osaka 590-0073 / JP
 [2004/24]
Representative(s)Böhm, Brigitte, et al
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Postfach 860 820
81635 München / DE
[N/P]
Former [2009/32]Böhm, Brigitte, et al
Weickmann & Weickmann Patentanwälte Postfach 860 820
81635 München / DE
Former [2004/24]Lewin, John Harvey
Takeda Euro IP Department, 11-12 Charles II Street
London SW1Y 4QU / GB
Application number, filing date02760703.522.08.2002
[2004/24]
WO2002JP08466
Priority number, dateJP2001025482624.08.2001         Original published format: JP 2001254826
[2004/24]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03018795
Date:06.03.2003
Language:EN
[2003/10]
Type: A1 Application with search report 
No.:EP1426440
Date:09.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 06.03.2003 takes the place of the publication of the European patent application.
[2004/24]
Type: B1 Patent specification 
No.:EP1426440
Date:16.06.2010
Language:EN
[2010/24]
Search report(s)International search report - published on:JP06.03.2003
(Supplementary) European search report - dispatched on:EP30.10.2006
ClassificationIPC:C07K14/705, C12N15/12
[2006/48]
CPC:
C07K14/47 (EP,US); A61K38/00 (EP,US)
Former IPC [2004/24]C12N15/09, C07K7/08, C07K14/705, C07K16/28, C12N5/10, C12P21/08, C12Q1/68, A61K38/17, A61K39/395, A61K48/00, G01N33/15, G01N33/50, G01N33/53, G01N33/566, G01N33/577
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/24]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:NEUES RFRP-3 UND DNA DAFÜR[2004/24]
English:NOVEL RFRP-3 AND DNA THEREOF[2004/24]
French:NOUVEAU PEPTIDE RFRP-3 ET ADN DE CELUI-CI[2004/24]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase23.02.2004Translation filed 
23.02.2004National basic fee paid 
23.02.2004Search fee paid 
23.02.2004Designation fee(s) paid 
23.02.2004Examination fee paid 
Examination procedure23.02.2004Examination requested  [2004/24]
08.02.2008Despatch of a communication from the examining division (Time limit: M06)
04.08.2008Reply to a communication from the examining division
29.08.2008Despatch of a communication from the examining division (Time limit: M06)
16.01.2009Reply to a communication from the examining division
30.01.2009Despatch of a communication from the examining division (Time limit: M06)
06.08.2009Reply to a communication from the examining division
23.10.2009Communication of intention to grant the patent
26.02.2010Fee for grant paid
26.02.2010Fee for publishing/printing paid
Opposition(s)17.03.2011No opposition filed within time limit [2011/21]
Fees paidRenewal fee
23.02.2004Renewal fee patent year 03
12.08.2005Renewal fee patent year 04
14.08.2006Renewal fee patent year 05
14.08.2007Renewal fee patent year 06
31.03.2008Renewal fee patent year 07
12.08.2009Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
TR16.06.2010
IE22.08.2010
LU22.08.2010
MC31.08.2010
BG16.09.2010
GR17.09.2010
ES27.09.2010
PT18.10.2010
[2013/46]
Former [2013/42]AT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
TR16.06.2010
IE22.08.2010
LU22.08.2010
MC31.08.2010
BG16.09.2010
GR17.09.2010
PT18.10.2010
Former [2012/47]AT16.06.2010
BE16.06.2010
BG16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
TR16.06.2010
IE22.08.2010
LU22.08.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2012/44]AT16.06.2010
BE16.06.2010
BG16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
IE22.08.2010
LU22.08.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2012/41]AT16.06.2010
BE16.06.2010
BG16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
IE22.08.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2011/35]AT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
IE22.08.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2011/19]AT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
DK16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2011/15]AT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
MC31.08.2010
GR17.09.2010
PT18.10.2010
Former [2011/14]AT16.06.2010
BE16.06.2010
CY16.06.2010
CZ16.06.2010
EE16.06.2010
FI16.06.2010
IT16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
GR17.09.2010
PT18.10.2010
Former [2011/10]AT16.06.2010
CY16.06.2010
CZ16.06.2010
EE16.06.2010
FI16.06.2010
NL16.06.2010
SE16.06.2010
SK16.06.2010
GR17.09.2010
PT18.10.2010
Former [2011/08]AT16.06.2010
CY16.06.2010
EE16.06.2010
FI16.06.2010
NL16.06.2010
SE16.06.2010
GR17.09.2010
Former [2011/05]AT16.06.2010
CY16.06.2010
FI16.06.2010
SE16.06.2010
GR17.09.2010
Former [2011/01]AT16.06.2010
FI16.06.2010
SE16.06.2010
GR17.09.2010
Former [2010/50]AT16.06.2010
FI16.06.2010
SE16.06.2010
Former [2010/49]AT16.06.2010
SE16.06.2010
Documents cited:Search[PX]EP1132405  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [PX] 1-35,43-50 * see the whole document, especially page 9, lines 1 to 9 *;
 [PX]CA2401946  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [PX] 1-35,43-50* see the whole document *
International search[X]WO0029441  (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al);
 [A]  - HINUMA S. ET AL., "New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals", NATURE CELL BIOLOGY, (2000), vol. 2, pages 703 - 708, XP002942274

DOI:   http://dx.doi.org/10.1038/35036326
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.